ROPIVACAINE Side Effects

6428946-3 | Cardio-respiratory Arrest, Convulsion
on Nov 04, 2009 Female patient from UNITED STATES , 48 years of age, weighting 150.4 lb, was diagnosed with nerve block and was treated with Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, convulsion. Ropivacaine dosage: 14 Ml X1 Infiltrated. During the same period patient was treated with FENTANYL 2 ML/AMPULE (1 Ml X1 Infiltrated) (View Fentanyl 2 Ml/ampule Review and Fentanyl 2 Ml/ampule Label ).

6411742-0 | Eyelid Ptosis, Quadriparesis
Patient was taking Ropivacaine (View Usage). Patient had the following side effects: eyelid ptosis, quadriparesis on Oct 16, 2009 from SPAIN Additional patient health information: Female patient , 71 years of age, weighting 149.9 lb, was diagnosed with nerve block, anaesthesia, hypertension and. Ropivacaine dosage: . During the same period patient was treated with MEPIVACAINE HCL (View Mepivacaine Hcl Review and Mepivacaine Hcl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), ALFENTANIL (View Alfentanil Review and Alfentanil Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized.

6396564-1 | Phrenic Nerve Paralysis
Adverse event was reported on Sep 15, 2009 by a Female patient taking Ropivacaine (View Usage) (Dosage: 1:200.000) was diagnosed with nerve block and. Location: UNITED STATES , 38 years of age, weighting 213.8 lb, After Ropivacaine was administered, patient had the following side effects: phrenic nerve paralysis. During the same period patient was treated with EPINEPHRINE (View Epinephrine Review and Epinephrine Label ).

6249923-1 | Overdose, Paraesthesia
on Jun 18, 2009 Female patient from AUSTRALIA , 37 years of age, was treated with Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: overdose, paraesthesia. Ropivacaine dosage: Two Tap Blocks At 2x8 Ml/hr.


6227296-8 | Cardiac Arrest, Grand Mal Convulsion
on Jun 08, 2009 Female patient from FRANCE , 92 years of age, was diagnosed with local anaesthesia and was treated with Ropivacaine (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), grand mal convulsion. Ropivacaine dosage: .

6183719-4 | Fall
Patient was taking Ropivacaine (View Usage). After Ropivacaine was administered, patient had the following side effects: fall (What is fall?) on Apr 30, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 81 years of age, was diagnosed with nerve block and. Ropivacaine dosage: .

6173674-5 | Cardiac Arrest
Adverse event was reported on Apr 27, 2009 by a Female patient taking Ropivacaine (View Usage) (Dosage: ) was diagnosed with local anaesthesia and. Location: FRANCE , 33 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?).

6150387-7 | Nerve Root Injury
on Apr 01, 2009 Female patient from CANADA , 50 years of age, was diagnosed with local anaesthesia and was treated with Ropivacaine (View Usage). Patient had the following side effects: nerve root injury. Ropivacaine dosage: . During the same period patient was treated with ADRENALIN (2.5 Ug/ml) (View Adrenalin Review and Adrenalin Label ).

6112850-4 | Renal Failure Acute
on Mar 03, 2009 Female patient from FRANCE , 61 years of age, weighting 160.9 lb, was diagnosed with postoperative analgesia and was treated with Ropivacaine (View Usage). After Ropivacaine was administered, patient had the following side effects: renal failure acute. Ropivacaine dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL (View Sufentanil Review and Sufentanil Label ), KETAMINE HCL (View Ketamine Hcl Review and Ketamine Hcl Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TRAMADOL (View Tramadol Review and Tramadol Label ). Patient was hospitalized.

6068058-4 | Adrenergic Syndrome, Akinesia, Atelectasis, Cardiac Arrest, Diaphragmatic Paralysis, Ejection Fraction, Electrocardiogram St Segment Elevation, Hypercapnia, Hypertension
Patient was taking Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: adrenergic syndrome, akinesia, atelectasis, cardiac arrest (What is cardiac arrest?), diaphragmatic paralysis, ejection fraction, electrocardiogram st segment elevation, hypercapnia, hypertension on Feb 04, 2009 from BRAZIL Additional patient health information: Female patient , 61 years of age, was diagnosed with anaesthesia and. Ropivacaine dosage: .

6036536-X | Peripheral Nerve Injury
Adverse event was reported on Jan 08, 2009 by a Female patient taking Ropivacaine (View Usage) (Dosage: ) was diagnosed with anaesthesia, ovarian operation and. Location: JAPAN , 49 years of age, weighting 125.7 lb, Patient had the following side effects: peripheral nerve injury. During the same period patient was treated with MEPIVACAINE HCL (View Mepivacaine Hcl Review and Mepivacaine Hcl Label ), FENTANYL CITRATE (3 Ug/ml At 4 Ml/hour) (View Fentanyl Citrate Review and Fentanyl Citrate Label ).

6031446-6 | Catheter Site Pain, Neuropathy Peripheral, Peripheral Nerve Injury
on Dec 24, 2008 Female patient from JAPAN , 49 years of age, weighting 125.7 lb, was diagnosed with anaesthesia, ovarian operation and was treated with Ropivacaine (View Usage). After Ropivacaine was administered, patient had the following side effects: catheter site pain, neuropathy peripheral, peripheral nerve injury. Ropivacaine dosage: . During the same period patient was treated with MEPIVACAINE HCL (View Mepivacaine Hcl Review and Mepivacaine Hcl Label ), FENTANYL 100 (3 Ug/ml At 4 Ml/hour) (View Fentanyl-100 Review and Fentanyl-100 Label ).

5956653-X | Cardiac Arrest, Convulsion, Ventricular Tachycardia
on Dec 17, 2007 Female patient from JAPAN , 39 years of age, weighting 114.6 lb, was diagnosed with epidural anaesthesia and was treated with Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), convulsion, ventricular tachycardia. Ropivacaine dosage: . During the same period patient was treated with ASPIRIN (Every 3 Days.) (View Aspirin Review and Aspirin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5951349-2 | Convulsion, Eye Movement Disorder, Somnolence, Tonic Clonic Movements
Patient was taking Ropivacaine (View Usage). Patient had the following side effects: convulsion, eye movement disorder, somnolence, tonic clonic movements on Nov 11, 2008 from UNITED STATES Additional patient health information: Male patient , 57 years of age, weighting 205.0 lb, was diagnosed with nerve block and. Ropivacaine dosage: 14 Ml Once Other. Patient was hospitalized and became disabled.

5934020-2 | Grand Mal Convulsion, Loss Of Consciousness
Adverse event was reported on Oct 27, 2008 by a Male patient taking Ropivacaine (View Usage) (Dosage: 20 Mls Of 7.5 Mg Ml-1 Injected Over One Minute In 3 - 4 Increments) was diagnosed with local anaesthesia and. Location: JAPAN , 18 years of age, weighting 132.3 lb, After Ropivacaine was administered, patient had the following side effects: grand mal convulsion, loss of consciousness. During the same period patient was treated with HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), ATROPINE (View Atropine Review and Atropine Label ).

5931419-5 | Convulsion
on Oct 24, 2008 Male patient from UNITED STATES , 39 years of age, weighting 425.0 lb, was diagnosed with nerve block and was treated with Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Ropivacaine dosage: 30 Ml Once Other.

5883963-7 | Hypersensitivity
on Sep 10, 2008 Female patient from CHINA , 48 years of age, weighting 138.9 lb, was diagnosed with surgery (What is surgery?) and was treated with Ropivacaine (View Usage). Patient had the following side effects: hypersensitivity. Ropivacaine dosage: 9 Ml. During the same period patient was treated with ATROPINE (View Atropine Review and Atropine Label ), PHENOBARBITAL SODIUM 100MG CAP (View Phenobarbital Sodium 100mg Cap Review and Phenobarbital Sodium 100mg Cap Label ).

5879622-7 | Blood Pressure Decreased, Dysphoria, Heart Rate Increased, Hypoaesthesia Oral, Increased Upper Airway Secretion, Oedema Peripheral, Oxygen Saturation Decreased, Sensation Of Foreign Body
Patient was taking Ropivacaine (View Usage). After Ropivacaine was administered, patient had the following side effects: blood pressure decreased, dysphoria, heart rate increased, hypoaesthesia oral, increased upper airway secretion, oedema peripheral, oxygen saturation decreased, sensation of foreign body on Sep 03, 2008 from CHINA Additional patient health information: Male patient , 26 years of age, weighting 132.3 lb, was diagnosed with surgery (What is surgery?) and. Ropivacaine dosage: . During the same period patient was treated with PHENOBARBITAL SODIUM 100MG CAP (View Phenobarbital Sodium 100mg Cap Review and Phenobarbital Sodium 100mg Cap Label ), ATROPINE (View Atropine Review and Atropine Label ).

5877889-2 | Hypersensitivity
Adverse event was reported on Sep 03, 2008 by a Female patient taking Ropivacaine (View Usage) (Dosage: 9 Ml) was diagnosed with surgery (What is surgery?) and. Location: CHINA , 48 years of age, weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: hypersensitivity. During the same period patient was treated with ATROPINE (View Atropine Review and Atropine Label ), PHENOBARBITAL SODIUM 100MG CAP (View Phenobarbital Sodium 100mg Cap Review and Phenobarbital Sodium 100mg Cap Label ).

5876839-2 | Convulsion, Muscle Spasms
on Sep 01, 2008 Male patient from CHINA , 45 years of age, weighting 149.9 lb, was diagnosed with anaesthesia and was treated with Ropivacaine (View Usage). Patient had the following side effects: convulsion, muscle spasms. Ropivacaine dosage: .

5845546-4 | Anaphylactic Reaction, Delayed Recovery From Anaesthesia
on Aug 11, 2008 Female patient from CHINA , 31 years of age, was diagnosed with anaesthesia and was treated with Ropivacaine (View Usage). After Ropivacaine was administered, patient had the following side effects: anaphylactic reaction, delayed recovery from anaesthesia. Ropivacaine dosage: .

5845062-X | Convulsion, Muscle Spasms
Patient was taking Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, muscle spasms on Aug 12, 2008 from CHINA Additional patient health information: Male patient , 45 years of age, was diagnosed with anaesthesia and. Ropivacaine dosage: .

5828541-0 | Anaphylactic Reaction, Delayed Recovery From Anaesthesia
Adverse event was reported on Jul 22, 2008 by a Female patient taking Ropivacaine (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: CHINA , 31 years of age, Patient had the following side effects: anaphylactic reaction, delayed recovery from anaesthesia.

5777128-7 | Grand Mal Convulsion, Loss Of Consciousness
on Jun 10, 2008 Male patient from FINLAND , 48 years of age, weighting 220.5 lb, was diagnosed with tinnitus (What is tinnitus?) and was treated with Ropivacaine (View Usage). After Ropivacaine was administered, patient had the following side effects: grand mal convulsion, loss of consciousness. Ropivacaine dosage: . During the same period patient was treated with NASAL STEROID (View Nasal Steroid Review and Nasal Steroid Label ), OMEPRATSOL (View Omepratsol Review and Omepratsol Label ), IMIDAZOPYRIDINE (View Imidazopyridine Review and Imidazopyridine Label ).

5747722-8 | Grand Mal Convulsion
on May 22, 2008 Male patient from UNITED STATES , 16 years of age, was diagnosed with nerve block and was treated with Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion. Ropivacaine dosage: . During the same period patient was treated with WELLBUTRIN SR (View Wellbutrin Sr Review and Wellbutrin Sr Label ), SALINE WITH EPINEPHRINE (Test Dose. With Epinephrine 1:200,000) (View Saline With Epinephrine Review and Saline With Epinephrine Label ).

5715967-9 | Weight Bearing Difficulty
Patient was taking Ropivacaine (View Usage). Patient had the following side effects: weight bearing difficulty on Apr 16, 2008 from AUSTRALIA Additional patient health information: Male patient , 47 years of age, was diagnosed with nerve block, induction of anaesthesia, prophylaxis of nausea and vomiting and. Ropivacaine dosage: . During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), PROPOFOL (View Propofol Review and Propofol Label ), OXYGEN/AIR (View Oxygen/air Review and Oxygen/air Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ). Patient was hospitalized.

5714932-5 | Bradycardia, Cerebrovascular Disorder, Hypotension, Loss Of Consciousness, Respiratory Arrest
Adverse event was reported on Apr 14, 2008 by a Female patient taking Ropivacaine (View Usage) (Dosage: Test Dose) was diagnosed with anaesthesia and. Location: SPAIN , 69 years of age, After Ropivacaine was administered, patient had the following side effects: bradycardia, cerebrovascular disorder, hypotension, loss of consciousness, respiratory arrest. During the same period patient was treated with SULPIRIDE (View Sulpiride Review and Sulpiride Label ), DOPIDOGREL (View Dopidogrel Review and Dopidogrel Label ), PERINDROPIL (View Perindropil Review and Perindropil Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), TRANSDERMAL NITROGYLCERIN (View Transdermal Nitrogylcerin Review and Transdermal Nitrogylcerin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

5643209-1 | Loss Of Consciousness, Muscle Spasms
on Feb 26, 2008 Female patient from CHINA , 25 years of age, weighting 143.3 lb, was diagnosed with anaesthesia and was treated with Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, muscle spasms. Ropivacaine dosage: . During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ).

5573493-4 | Cardiac Arrest, Convulsion, Ventricular Tachycardia
on Dec 17, 2007 Female patient from JAPAN , 39 years of age, weighting 114.6 lb, was diagnosed with epidural anaesthesia and was treated with Ropivacaine (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), convulsion, ventricular tachycardia. Ropivacaine dosage: . During the same period patient was treated with ASPIRIN (Every 3 Days.) (View Aspirin Review and Aspirin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5571072-6 | Nervous System Disorder
Patient was taking Ropivacaine (View Usage). After Ropivacaine was administered, patient had the following side effects: nervous system disorder on Dec 18, 2007 from CHINA Additional patient health information: Female patient , 44 years of age, was diagnosed with spinal anaesthesia, epidural anaesthesia and. Ropivacaine dosage: Spinal. During the same period patient was treated with GLUCOSE (View Glucose Review and Glucose Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), ONDASETRON (View Ondasetron Review and Ondasetron Label ). Patient was hospitalized.

5571071-4 | Nervous System Disorder
Adverse event was reported on Dec 18, 2007 by a Female patient taking Ropivacaine (View Usage) (Dosage: Spinal) was diagnosed with spinal anaesthesia, epidural anaesthesia and. Location: CHINA , 67 years of age, Patient experienced the following unwanted or unexpected effects: nervous system disorder. During the same period patient was treated with GLUCOSE (View Glucose Review and Glucose Label ). Patient was hospitalized.

5542031-4 | Loss Of Consciousness, Respiratory Arrest
on Dec 05, 2007 Male patient from CHINA , 35 years of age, was diagnosed with anaesthesia and was treated with Ropivacaine (View Usage). Patient had the following side effects: loss of consciousness, respiratory arrest. Ropivacaine dosage: .

5476025-4 | Loss Of Consciousness
on Sep 24, 2007 Female patient from BELGIUM , 30 years of age, was diagnosed with anaesthesia, feeling of relaxation and was treated with Ropivacaine (View Usage). After Ropivacaine was administered, patient had the following side effects: loss of consciousness. Ropivacaine dosage: . During the same period patient was treated with SUFENTANIL (View Sufentanil Review and Sufentanil Label ).

5412430-X | Cardiac Failure, Depressed Level Of Consciousness, Dilatation Ventricular, Haemodynamic Instability, Left Atrial Dilatation, Metabolic Acidosis, Oliguria, Respiratory Acidosis, Therapeutic Response Increased
Patient was taking Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, depressed level of consciousness, dilatation ventricular, haemodynamic instability, left atrial dilatation, metabolic acidosis, oliguria, respiratory acidosis, therapeutic response increased on Aug 08, 2007 from PORTUGAL Additional patient health information: Male patient , 71 years of age, was diagnosed with epidural anaesthesia and. Ropivacaine dosage: . During the same period patient was treated with MORPHINE (Loading Dose) (View Morphine Review and Morphine Label ).

5386726-4 | Hallucination, Visual, Hyperacusis, Loss Of Consciousness, Muscle Rigidity, Paraesthesia, Speech Disorder
Adverse event was reported on Jul 06, 2007 by a Male patient taking Ropivacaine (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia, hypertension and. Location: ITALY , 52 years of age, Patient had the following side effects: hallucination, visual, hyperacusis, loss of consciousness, muscle rigidity, paraesthesia, speech disorder. During the same period patient was treated with BETA BLOCKER (View Beta-blocker Review and Beta-blocker Label ), CA++ ANTAGONIST (View Ca++-antagonist Review and Ca++-antagonist Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ).

5382515-5 | Anaesthetic Complication, Apnoea, Hypotension, Mydriasis
on Jun 01, 2007 Male patient from BRAZIL , 34 years of age, weighting 213.8 lb, was treated with Ropivacaine (View Usage). After Ropivacaine was administered, patient had the following side effects: anaesthetic complication, apnoea, hypotension, mydriasis. Ropivacaine dosage: .

5350680-1 | Anaesthetic Complication, Apnoea, Hypotension, Mydriasis
on Jun 01, 2007 Male patient from BRAZIL , 34 years of age, weighting 213.8 lb, was treated with Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: anaesthetic complication, apnoea, hypotension, mydriasis. Ropivacaine dosage: .

5228930-1 | Spinal Cord Ischaemia
Patient was taking Ropivacaine (View Usage). Patient had the following side effects: spinal cord ischaemia on Jan 22, 2007 from FRANCE Additional patient health information: Male patient , 76 years of age, was diagnosed with analgesic effect, induction of anaesthesia and. Ropivacaine dosage: Bolus. During the same period patient was treated with SUFENTANIL CITRATE (Bolus) (View Sufentanil Citrate Review and Sufentanil Citrate Label ).

5089011-3 | Accidental Overdose, Bradycardia, Cardiac Arrest, Dizziness, Grand Mal Convulsion, Heart Rate Increased, Incorrect Dose Administered, Loss Of Consciousness, Somnolence
Adverse event was reported on Aug 21, 2006 by a Female patient taking Ropivacaine (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: GERMANY , 84 years of age, weighting 110.2 lb, After Ropivacaine was administered, patient had the following side effects: accidental overdose, bradycardia, cardiac arrest (What is cardiac arrest?), dizziness (What is dizziness?), grand mal convulsion, heart rate increased, incorrect dose administered, loss of consciousness, somnolence. During the same period patient was treated with MIDAZOLAM (Prior To Start Of Anaesthesia) (View Midazolam Review and Midazolam Label ).

5059884-9 | Post Procedural Complication, Respiratory Arrest
on Jul 12, 2006 Female patient from JAPAN , 57 years of age, weighting 88.18 lb, was treated with Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: post procedural complication, respiratory arrest. Ropivacaine dosage: 1.5 Ml/hr Unk. During the same period patient was treated with MEPIVACAINE HCL (View Mepivacaine Hcl Review and Mepivacaine Hcl Label ), FENTANYL TRANSDERMAL SYSTEM (Unk) (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), PROPOFOL (Unk) (View Propofol Review and Propofol Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), PENTAGIN (15 Mg) (View Pentagin Review and Pentagin Label ).

5045238-8 | Convulsion, Facial Palsy, Hemiparesis, Obstructive Airways Disorder
on Jun 26, 2006 Male patient from NETHERLANDS , 36 years of age, weighting 176.4 lb, was diagnosed with local anaesthesia, sedation and was treated with Ropivacaine (View Usage). Patient had the following side effects: convulsion, facial palsy, hemiparesis, obstructive airways disorder. Ropivacaine dosage: 5 Ml 1% Ropivacaine. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), OXYBUPROCAINE (0.4 %) (View Oxybuprocaine Review and Oxybuprocaine Label ).

5002131-4 | Neuromuscular Blockade
Patient was taking Ropivacaine (View Usage). After Ropivacaine was administered, patient had the following side effects: neuromuscular blockade on May 04, 2006 from SPAIN Additional patient health information: Male patient , child 11 years of age, weighting 77.16 lb, was diagnosed with postoperative analgesia, anaesthesia, neuromuscular blockade and. Ropivacaine dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), REMIFENTANYL (View Remifentanyl Review and Remifentanyl Label ), MIVACURIUM (View Mivacurium Review and Mivacurium Label ).

4973042-5 | Blood Pressure Increased, Heart Rate Increased, Paraplegia, Spinal Cord Infarction
Adverse event was reported on Sep 12, 2005 by a Female patient taking Ropivacaine (View Usage) (Dosage: 1ml Of 1% Solution) was diagnosed with epidural anaesthesia, musculoskeletal chest pain, x-ray (What is x-ray?), sedation and. Location: UNITED STATES , 67 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure increased, heart rate increased, paraplegia, spinal cord infarction. During the same period patient was treated with TRIAMCINOLONE ACETONIDE (View Triamcinolone Acetonide Review and Triamcinolone Acetonide Label ), ISOVUE 128 (View Isovue-128 Review and Isovue-128 Label ), ISOVUE 128 (View Isovue-128 Review and Isovue-128 Label ), ISOVUE 128 (View Isovue-128 Review and Isovue-128 Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ).

4962908-8 | Dyspnoea, Flail Chest, Hyperhidrosis
on Mar 22, 2006 Female patient from FRANCE , 74 years of age, was diagnosed with anaesthesia, local anaesthesia and was treated with Ropivacaine (View Usage). Patient had the following side effects: dyspnoea, flail chest, hyperhidrosis. Ropivacaine dosage: Injected Slowly In Dvivided Doses.. During the same period patient was treated with LIDOCAINE (Injected Slowly In Divided Doses.) (View Lidocaine Review and Lidocaine Label ), PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), ATRACURIUM (View Atracurium Review and Atracurium Label ).

4961022-5 | Flail Chest, Respiratory Failure
on Mar 22, 2006 Female patient from FRANCE , 72 years of age, was diagnosed with anaesthesia and was treated with Ropivacaine (View Usage). After Ropivacaine was administered, patient had the following side effects: flail chest, respiratory failure. Ropivacaine dosage: .

4921579-7 | Horner's Syndrome
Patient was taking Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: horner's syndrome on Feb 13, 2006 from GREECE Additional patient health information: Female patient , 27 years of age, weighting 165.3 lb, was diagnosed with anaesthesia and. Ropivacaine dosage: . During the same period patient was treated with LACTATED RINGER'S (1000-1300 Ml) (View Lactated Ringer's Review and Lactated Ringer's Label ).

4862484-4 | Polyneuropathy
Adverse event was reported on Dec 12, 2005 by a Female patient taking Ropivacaine (View Usage) (Dosage: ) was diagnosed with postoperative analgesia and. Location: FRANCE , 50 years of age, Patient had the following side effects: polyneuropathy.

4779565-6 | Paraplegia, Spinal Cord Infarction
on Sep 12, 2005 Female patient from UNITED STATES , 67 years of age, was diagnosed with epidural anaesthesia, chest wall pain and was treated with Ropivacaine (View Usage). After Ropivacaine was administered, patient had the following side effects: paraplegia, spinal cord infarction. Ropivacaine dosage: . During the same period patient was treated with TRIAMCINOLONE ACETONIDE (View Triamcinolone Acetonide Review and Triamcinolone Acetonide Label ).

4773020-5 | Cholecystitis, Insomnia
on Sep 05, 2005 Male patient from TAIWAN, PROVINCE OF CHINA , 79 years of age, was diagnosed with anaesthesia, herpes zoster, post herpetic neuralgia and was treated with Ropivacaine (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis, insomnia. Ropivacaine dosage: . During the same period patient was treated with VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ), IMIPRAMINE (View Imipramine Review and Imipramine Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), TRAMADOL (View Tramadol Review and Tramadol Label ).

4695538-6 | Respiratory Distress, Vocal Cord Paralysis
Patient was taking Ropivacaine (View Usage). Patient had the following side effects: respiratory distress, vocal cord paralysis on May 09, 2005 from Additional patient health information: Female patient , 73 years of age, was diagnosed with nerve block, thyroidectomy and. Ropivacaine dosage: . During the same period patient was treated with REMIFENTANIL (0.03 Ug Kg-1 Min-1) (View Remifentanil Review and Remifentanil Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).